4 ms·

Control-f on "cure". Nothing. Very misleading title.

• vikramkr 6y ago
  It's a treatment that stops viral replication within four days. It might not shut down cytokine storm, but if administered earlier, it stops replication which would be a cure if it works. Biotechs tend to avoid the word cure early on, you'll see the word treatment, because cure is a word that's hard to define and often meaningless or with blurry boundaries.
  • aazaa 6y ago
    > Among the antibodies showing neutralizing activity, one antibody stood out for its ability to completely block SARS-CoV-2 infection of healthy cells in the experiments. STI-1499 completely neutralized the virus infectivity at a very low antibody dose, making it a prime candidate for further testing and development. Initial biochemical and biophysical analyses also indicate STI-1499 is a potentially strong antibody drug candidate. https://investors.sorrentotherapeutics.com/node/11241/pdf https://investors.sorrentotherapeutics.com/node/11241/pdf This is as far from a "cure" or "treatment" as the Wright Brothers were from Apollo 11. In vitro results are a necessary, but insufficient path along the trajectory of developing a drug. Heck, this press release doesn't even mention in vivo experiments. Everything is on cells. Drug development is absolutely littered with the corpses of promising in vitro studies. Calling the experiments have have been run anything other than "preliminary work" is misleading.